Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study

Mark Thursz, Patrick Sequeira Kamath, Philippe Mathurin, Gyongyi Szabo, Vijay Shah

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

A joint meeting of the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD) was held in London on September 30 and October 1, 2017. The goals of the meeting were to identify areas of broad agreement and disagreement, develop consensus, and determine future directions to ultimately reduce the burden, morbidity, and mortality of alcohol-related liver disease (previously termed alcoholic liver disease). The specific aims of the meeting were to identify unmet needs and areas for future investigation, in order to reduce alcohol consumption, develop markers for diagnosis and prognosis of disease, and create a framework to test novel pharmacological agents with pre-specified treatment endpoints.

Original languageEnglish (US)
Pages (from-to)521-530
Number of pages10
JournalJournal of Hepatology
Volume70
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Alcoholic Liver Diseases
Alcohol Drinking
Liver Diseases
Consensus
Alcohols
Pharmacology
Morbidity
Mortality
Direction compound

Keywords

  • Alcohol
  • ALD
  • Biomarkers
  • Clinical trials
  • Endpoints
  • Epidemiology
  • Public health
  • Unmet needs

ASJC Scopus subject areas

  • Hepatology

Cite this

Alcohol-related liver disease : Areas of consensus, unmet needs and opportunities for further study. / Thursz, Mark; Kamath, Patrick Sequeira; Mathurin, Philippe; Szabo, Gyongyi; Shah, Vijay.

In: Journal of Hepatology, Vol. 70, No. 3, 01.03.2019, p. 521-530.

Research output: Contribution to journalReview article

@article{070d01b2fc314d6191a1c277d1dc1da8,
title = "Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study",
abstract = "A joint meeting of the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD) was held in London on September 30 and October 1, 2017. The goals of the meeting were to identify areas of broad agreement and disagreement, develop consensus, and determine future directions to ultimately reduce the burden, morbidity, and mortality of alcohol-related liver disease (previously termed alcoholic liver disease). The specific aims of the meeting were to identify unmet needs and areas for future investigation, in order to reduce alcohol consumption, develop markers for diagnosis and prognosis of disease, and create a framework to test novel pharmacological agents with pre-specified treatment endpoints.",
keywords = "Alcohol, ALD, Biomarkers, Clinical trials, Endpoints, Epidemiology, Public health, Unmet needs",
author = "Mark Thursz and Kamath, {Patrick Sequeira} and Philippe Mathurin and Gyongyi Szabo and Vijay Shah",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jhep.2018.10.041",
language = "English (US)",
volume = "70",
pages = "521--530",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Alcohol-related liver disease

T2 - Areas of consensus, unmet needs and opportunities for further study

AU - Thursz, Mark

AU - Kamath, Patrick Sequeira

AU - Mathurin, Philippe

AU - Szabo, Gyongyi

AU - Shah, Vijay

PY - 2019/3/1

Y1 - 2019/3/1

N2 - A joint meeting of the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD) was held in London on September 30 and October 1, 2017. The goals of the meeting were to identify areas of broad agreement and disagreement, develop consensus, and determine future directions to ultimately reduce the burden, morbidity, and mortality of alcohol-related liver disease (previously termed alcoholic liver disease). The specific aims of the meeting were to identify unmet needs and areas for future investigation, in order to reduce alcohol consumption, develop markers for diagnosis and prognosis of disease, and create a framework to test novel pharmacological agents with pre-specified treatment endpoints.

AB - A joint meeting of the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD) was held in London on September 30 and October 1, 2017. The goals of the meeting were to identify areas of broad agreement and disagreement, develop consensus, and determine future directions to ultimately reduce the burden, morbidity, and mortality of alcohol-related liver disease (previously termed alcoholic liver disease). The specific aims of the meeting were to identify unmet needs and areas for future investigation, in order to reduce alcohol consumption, develop markers for diagnosis and prognosis of disease, and create a framework to test novel pharmacological agents with pre-specified treatment endpoints.

KW - Alcohol

KW - ALD

KW - Biomarkers

KW - Clinical trials

KW - Endpoints

KW - Epidemiology

KW - Public health

KW - Unmet needs

UR - http://www.scopus.com/inward/record.url?scp=85060946230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060946230&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2018.10.041

DO - 10.1016/j.jhep.2018.10.041

M3 - Review article

C2 - 30658117

AN - SCOPUS:85060946230

VL - 70

SP - 521

EP - 530

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 3

ER -